While we have observed a role for MPZL3 in a HER3-dependent proliferative response in MET-amplified cells, it is unclear whether this is a specific requirement of Met-dependent transformation independent of HER3 or whether MPZL3 expression is associated with RTK amplification in cancer. The gene discussed is MPZL3; the disease is cancer.